<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nefr</journal-id><journal-title-group><journal-title xml:lang="ru">Нефрология</journal-title><trans-title-group xml:lang="en"><trans-title>Nephrology (Saint-Petersburg)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1561-6274</issn><issn pub-type="epub">2541-9439</issn><publisher><publisher-name>Pavlov First Saint-Petersburg State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.24884/1561-6274-2013-17-6-37-45</article-id><article-id custom-type="elpub" pub-id-type="custom">nefr-418</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ И ЛЕКЦИИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEWS AND LECTURES</subject></subj-group></article-categories><title-group><article-title>НЕФРОПАТИЯ ОЖИРЕНИЯ В ПЕДИАТРИИ</article-title><trans-title-group xml:lang="en"><trans-title>DIABETIC NEPHROPATHY IN PEDIATRICS</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Смирнова</surname><given-names>Н. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Smirnova</surname><given-names>N. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кафедра педиатрии</p><p>197022, Санкт-Петербург, ул. Л.Толстого, д. 6/8</p></bio><email xlink:type="simple">nephro-urokids@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Куприенко</surname><given-names>Н. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Kuprienko</surname><given-names>N. B.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кафедра педиатрии</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>Первый Санкт-Петербургский государственный медицинский университет им. акад. И.П.Павлова, ФГБУ «Федеральный центр сердца, крови и эндокринологии им. В.А. Алмазова»</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2013</year></pub-date><pub-date pub-type="epub"><day>10</day><month>06</month><year>2013</year></pub-date><volume>17</volume><issue>6</issue><fpage>37</fpage><lpage>45</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Смирнова Н.Н., Куприенко Н.Б., 2013</copyright-statement><copyright-year>2013</copyright-year><copyright-holder xml:lang="ru">Смирнова Н.Н., Куприенко Н.Б.</copyright-holder><copyright-holder xml:lang="en">Smirnova N.N., Kuprienko N.B.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.nephrolog.ru/jour/article/view/418">https://journal.nephrolog.ru/jour/article/view/418</self-uri><abstract><p>В обзоре приводятся сведения о морфологии и функции почек у детей при ожирении. Обсуждается влияние и взаимосвязь многочисленных патогенетических факторов, действующих на работу почки. Отмечено своеобразие нефропатии ожирения у детей по сравнению с взрослым организмом.</p></abstract><trans-abstract xml:lang="en"><p>The review provides information on morphology and function of kidneys in children in obesity. Participation and interrelationship of numerous pathogens, affecting kidney function are discussed. Originality of diabetic nephropathy in children in contrast with adults is mentioned.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>ожирение</kwd><kwd>дети</kwd><kwd>нефропатия</kwd></kwd-group><kwd-group xml:lang="en"><kwd>obesity</kwd><kwd>children</kwd><kwd>nephropathy</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">World Health Organization. Childhood overweight and obesity. http://www.who.int/dietphysicalactivity/childhood/en/ 2013</mixed-citation><mixed-citation xml:lang="en">World Health Organization. Childhood overweight and obesity. http://www.who.int/dietphysicalactivity/childhood/en/ 2013</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Steven MS, Jatinder B (ed). Obesity in children. MBBS// emedicine medscape.com/article/985333-overview 2012</mixed-citation><mixed-citation xml:lang="en">Steven MS, Jatinder B (ed). Obesity in children. MBBS// emedicine medscape.com/article/985333-overview 2012</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Overweight, obesity and the development of stage 3 CKD: the Framingham Heart Study. Am J Kidney Dis 2008; 52(1): 39-48</mixed-citation><mixed-citation xml:lang="en">Overweight, obesity and the development of stage 3 CKD: the Framingham Heart Study. Am J Kidney Dis 2008; 52(1): 39-48</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Freemark M. Pediatric Obesity: Etiology, Pathogenesis, and Treatment. Humana Press, New York, 2010; 27-30</mixed-citation><mixed-citation xml:lang="en">Freemark M. Pediatric Obesity: Etiology, Pathogenesis, and Treatment. Humana Press, New York, 2010; 27-30</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Шабалов НП (ред). Педиатрия. Учебник для медицинских вузов. Спец Лит, СПб., 2010; Приложения, 880</mixed-citation><mixed-citation xml:lang="en">Шабалов НП (ред). Педиатрия. Учебник для медицинских вузов. Спец Лит, СПб., 2010; Приложения, 880</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Lahti-Koski M, Gill T. Defining Childhood Obesity. Pediatr Adolesc Med Basel Karger 2004; 9: 1-19</mixed-citation><mixed-citation xml:lang="en">Lahti-Koski M, Gill T. Defining Childhood Obesity. Pediatr Adolesc Med Basel Karger 2004; 9: 1-19</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Barker DJ. Adult consequences of fetal growth restriction. Clin Obstet Gynecol 2006; 49: 270-283</mixed-citation><mixed-citation xml:lang="en">Barker DJ. Adult consequences of fetal growth restriction. Clin Obstet Gynecol 2006; 49: 270-283</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Schwimmer JA, Markowitz GS, Valeri AM et al. Secondary focal segmental glomerulosclerosis in non-obese patients with increased muscle mass. Clin Nephrol 2003; 60(4): 233-241</mixed-citation><mixed-citation xml:lang="en">Schwimmer JA, Markowitz GS, Valeri AM et al. Secondary focal segmental glomerulosclerosis in non-obese patients with increased muscle mass. Clin Nephrol 2003; 60(4): 233-241</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Praga M, Hernandez E, Herrero JC et al. Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy. Kidney Int 2000; 58: 2111-2118</mixed-citation><mixed-citation xml:lang="en">Praga M, Hernandez E, Herrero JC et al. Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy. Kidney Int 2000; 58: 2111-2118</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Carolin LA, Rodriguez MM. Obesity-related Nephropathy in Children. Pediatr Health 2009; 3(2): 141-153</mixed-citation><mixed-citation xml:lang="en">Carolin LA, Rodriguez MM. Obesity-related Nephropathy in Children. Pediatr Health 2009; 3(2): 141-153</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Serra A, Romero R, Lopez D et al. Renal injury in the extremely obese patients with normal renal function. Kidney Int 2008; 73: 947-955</mixed-citation><mixed-citation xml:lang="en">Serra A, Romero R, Lopez D et al. Renal injury in the extremely obese patients with normal renal function. Kidney Int 2008; 73: 947-955</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Rea DJ, Heimbach JK, Grande JP et al. Glomerular volume and renal histology in obese and non-obese living kidney donors. Kidney Int 2006; 70: 1636-1641</mixed-citation><mixed-citation xml:lang="en">Rea DJ, Heimbach JK, Grande JP et al. Glomerular volume and renal histology in obese and non-obese living kidney donors. Kidney Int 2006; 70: 1636-1641</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Kato S, Nazneen A, Nakashima Y et al. Pathological influence of obesity on renal structural changes in chronic kidney disease. Clin Exp Nephrol 2009; 13: 332-340</mixed-citation><mixed-citation xml:lang="en">Kato S, Nazneen A, Nakashima Y et al. Pathological influence of obesity on renal structural changes in chronic kidney disease. Clin Exp Nephrol 2009; 13: 332-340</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Neeraja KH, Markowitz GS, Anthony MV et al. Obesityrelated glomerulopathy: an emerging epidemic. Kidney Int 2001; 59: 1498-1509</mixed-citation><mixed-citation xml:lang="en">Neeraja KH, Markowitz GS, Anthony MV et al. Obesityrelated glomerulopathy: an emerging epidemic. Kidney Int 2001; 59: 1498-1509</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Nesauro M, Franzese O. Review Article «Chronic Kidney Disease, Obesity, and Hypertension: The Role of Leptin and Adiponectin». Hindawi Publishing Corporation Int J Hypertension 2012; Article ID 943606, 7 pages doi: 10.1155/2012/943605</mixed-citation><mixed-citation xml:lang="en">Nesauro M, Franzese O. Review Article «Chronic Kidney Disease, Obesity, and Hypertension: The Role of Leptin and Adiponectin». Hindawi Publishing Corporation Int J Hypertension 2012; Article ID 943606, 7 pages doi: 10.1155/2012/943605</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Oda A, Taniguchi T, Yokoyama M. Leptin stimulates rat aortic smooth muscle cell proliferation and migration. Kobe J Medical Sci 2001; 47(3): 141-159</mixed-citation><mixed-citation xml:lang="en">Oda A, Taniguchi T, Yokoyama M. Leptin stimulates rat aortic smooth muscle cell proliferation and migration. Kobe J Medical Sci 2001; 47(3): 141-159</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Yamagishi SI, Edelstein D, Du XL et al. Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A. J Biol Chem 2001; 276(27): 25096-25100</mixed-citation><mixed-citation xml:lang="en">Yamagishi SI, Edelstein D, Du XL et al. Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A. J Biol Chem 2001; 276(27): 25096-25100</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Werner N, Nickenig G. From fat fighter to risk factor: the zigzag trek of leptin. Ateriosclerosis, Thrombosis and Vascular Biology 2004; 24(1): 7-9</mixed-citation><mixed-citation xml:lang="en">Werner N, Nickenig G. From fat fighter to risk factor: the zigzag trek of leptin. Ateriosclerosis, Thrombosis and Vascular Biology 2004; 24(1): 7-9</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Wolf G, Hamann A, Han D.C. et al. Leptin stimulates proliferation and TGF-β expression in renal glomerular endothelial cells: potential role in glomerulosclerosis. Kidney Int 1999; 56(3): 860-872</mixed-citation><mixed-citation xml:lang="en">Wolf G, Hamann A, Han D.C. et al. Leptin stimulates proliferation and TGF-β expression in renal glomerular endothelial cells: potential role in glomerulosclerosis. Kidney Int 1999; 56(3): 860-872</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Ballerman BJ A role for leptin in glomerulosclerosis. Kidney Int 1999; 56(3): 1154-1155</mixed-citation><mixed-citation xml:lang="en">Ballerman BJ A role for leptin in glomerulosclerosis. Kidney Int 1999; 56(3): 1154-1155</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Chagnac A, Weinstein T, Korzerts A, et al. Glomerular hemodynamic in severe obesity. Am J Physiol 2000; 278: F817-F822</mixed-citation><mixed-citation xml:lang="en">Chagnac A, Weinstein T, Korzerts A, et al. Glomerular hemodynamic in severe obesity. Am J Physiol 2000; 278: F817-F822</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Adamczak M, Wiecek A, Funahashi J et al. Deceased plasma adiponectin concentration in patients with essential hypertension. Am J Hypertesion 2003; 16 (1): 72-73</mixed-citation><mixed-citation xml:lang="en">Adamczak M, Wiecek A, Funahashi J et al. Deceased plasma adiponectin concentration in patients with essential hypertension. Am J Hypertesion 2003; 16 (1): 72-73</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Yan KCB, Xu A, Chow WS et al. Hypoadipinectinemia is associated with impaired endothelium-dependent vasodilation. J Clin Endocrin Metab 2004; 89(2): 765-769</mixed-citation><mixed-citation xml:lang="en">Yan KCB, Xu A, Chow WS et al. Hypoadipinectinemia is associated with impaired endothelium-dependent vasodilation. J Clin Endocrin Metab 2004; 89(2): 765-769</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Kostis V, Stabouli S, Papakatsika S et al. Mechanisms of obesity-induced hypertension. Review. Hypertension Res 2010; 33: 386-393</mixed-citation><mixed-citation xml:lang="en">Kostis V, Stabouli S, Papakatsika S et al. Mechanisms of obesity-induced hypertension. Review. Hypertension Res 2010; 33: 386-393</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Yano Y, Hoshide S, Ishikawa J et al. Differential impacts of adiponectin on low-grade albuminuria between obese and nonobese persons without diabetes. J Clin Hypertension 2007; 9(10): 775-782</mixed-citation><mixed-citation xml:lang="en">Yano Y, Hoshide S, Ishikawa J et al. Differential impacts of adiponectin on low-grade albuminuria between obese and nonobese persons without diabetes. J Clin Hypertension 2007; 9(10): 775-782</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Kacso IM, Bondor CI, Kacso G. Plasma adiponectin is related to the progression of kidney disease in type 2 diabetes patients. Scand J Clin Lab Investigation 2012; 72 (4): 333-339</mixed-citation><mixed-citation xml:lang="en">Kacso IM, Bondor CI, Kacso G. Plasma adiponectin is related to the progression of kidney disease in type 2 diabetes patients. Scand J Clin Lab Investigation 2012; 72 (4): 333-339</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Onyango BS. The effects of the adipocyte-secreted proteins resistin and visfatin on the pancreatic beta-cell. A thesis submitted in partial fulfillment of the requirements of the University of Wolverhampton for degree of Doctor of Philosophy 2009</mixed-citation><mixed-citation xml:lang="en">Onyango BS. The effects of the adipocyte-secreted proteins resistin and visfatin on the pancreatic beta-cell. A thesis submitted in partial fulfillment of the requirements of the University of Wolverhampton for degree of Doctor of Philosophy 2009</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Hall JE, Brands MW, Henegar JR, Shek EW Abnormal kidney function as a cause and a consequence of obesity hypertension. Clin Exp Pharmacol Physiol 1998; 25: 58-64</mixed-citation><mixed-citation xml:lang="en">Hall JE, Brands MW, Henegar JR, Shek EW Abnormal kidney function as a cause and a consequence of obesity hypertension. Clin Exp Pharmacol Physiol 1998; 25: 58-64</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Coward RJM, Welsh GI, Kopziell A et al. Nephrin is critical for the action of insulin on human glomerular podocytes. Diabetes 2007; 56: 1127-1135</mixed-citation><mixed-citation xml:lang="en">Coward RJM, Welsh GI, Kopziell A et al. Nephrin is critical for the action of insulin on human glomerular podocytes. Diabetes 2007; 56: 1127-1135</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Naumnik B, Mysliwiec M. Renal consequences of obesity. Med Sci Monit 2010; 16(8): RA163-170</mixed-citation><mixed-citation xml:lang="en">Naumnik B, Mysliwiec M. Renal consequences of obesity. Med Sci Monit 2010; 16(8): RA163-170</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Greenfield JR, Miller JW, Keogh JM et al. Modulation of blood pressure by central melanocortinergic pathways. NEJM 2009; 360: 44-52</mixed-citation><mixed-citation xml:lang="en">Greenfield JR, Miller JW, Keogh JM et al. Modulation of blood pressure by central melanocortinergic pathways. NEJM 2009; 360: 44-52</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Chagnac A, Herman M, Zingerman B et al. Obesityinduced glomerular hyperfiltration: its involvement in the pathogenesis of tubular sodium reabsorption. Nephrol Dial Transplant 2008; 23: 3946-3952</mixed-citation><mixed-citation xml:lang="en">Chagnac A, Herman M, Zingerman B et al. Obesityinduced glomerular hyperfiltration: its involvement in the pathogenesis of tubular sodium reabsorption. Nephrol Dial Transplant 2008; 23: 3946-3952</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Bosma RJ, Van Der Heide JJ Oosterop EJ et al. Body mass index is associated with altered renal hemodynamics in non-obese healthy subjects. Kidney Int 2004; 65: 259-265</mixed-citation><mixed-citation xml:lang="en">Bosma RJ, Van Der Heide JJ Oosterop EJ et al. Body mass index is associated with altered renal hemodynamics in non-obese healthy subjects. Kidney Int 2004; 65: 259-265</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Chagnac A, Weinstein T, Korzets A et al. Glomerular hemodynamics in severe obesity. Am J Physiol renal Physiol 2000; 278: F817-F822</mixed-citation><mixed-citation xml:lang="en">Chagnac A, Weinstein T, Korzets A et al. Glomerular hemodynamics in severe obesity. Am J Physiol renal Physiol 2000; 278: F817-F822</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Ichikawa I, Hoyer JR, Seiler MW et al. mechanism of glomerulotubular balance in the setting of heterogeneous glomerular injury. Preservation of a close functional linkage between individual nephrons and surrounding microvasculature. J Clin Invest 1982; 69: 185-198</mixed-citation><mixed-citation xml:lang="en">Ichikawa I, Hoyer JR, Seiler MW et al. mechanism of glomerulotubular balance in the setting of heterogeneous glomerular injury. Preservation of a close functional linkage between individual nephrons and surrounding microvasculature. J Clin Invest 1982; 69: 185-198</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Vallon V, Blantz RC, Thomson S. Glomerular hyperfiltration and the salt paradox in early type 1 diabetes mellitus: a tubulocentric view. J Am Soc Nephrol 2003; 14:530-537</mixed-citation><mixed-citation xml:lang="en">Vallon V, Blantz RC, Thomson S. Glomerular hyperfiltration and the salt paradox in early type 1 diabetes mellitus: a tubulocentric view. J Am Soc Nephrol 2003; 14:530-537</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Hall JE. The kidney, hypertension, and obesity. Hypertension 2003; 41: 625-633</mixed-citation><mixed-citation xml:lang="en">Hall JE. The kidney, hypertension, and obesity. Hypertension 2003; 41: 625-633</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Chiolero A, Maillard M, nussberger J et al. Proximal sodium reabsorption: an independent determinant of blood pressure response to salt. Hypertension 2000; 36: 631-637</mixed-citation><mixed-citation xml:lang="en">Chiolero A, Maillard M, nussberger J et al. Proximal sodium reabsorption: an independent determinant of blood pressure response to salt. Hypertension 2000; 36: 631-637</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Arfvidsson B, Eklof b, Balfour J. Iliofemoral venous pressure correlates with intraabdominal pressure in morbidity obese patients. Vasc Endovascular Surg 2005; 39:505-509</mixed-citation><mixed-citation xml:lang="en">Arfvidsson B, Eklof b, Balfour J. Iliofemoral venous pressure correlates with intraabdominal pressure in morbidity obese patients. Vasc Endovascular Surg 2005; 39:505-509</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Karlsson C, Lindell K, Ottosson M et al. Human adipose tissue expresses angiotensinogen and enzymes required for its conversion to angiotensin II. J Clin Endocrinol Metab 1998;83(11):3925-3929</mixed-citation><mixed-citation xml:lang="en">Karlsson C, Lindell K, Ottosson M et al. Human adipose tissue expresses angiotensinogen and enzymes required for its conversion to angiotensin II. J Clin Endocrinol Metab 1998;83(11):3925-3929</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Sugrue M. Abdominal compartment syndrome. Curr Opin Crit Care 2005; 11:333-338</mixed-citation><mixed-citation xml:lang="en">Sugrue M. Abdominal compartment syndrome. Curr Opin Crit Care 2005; 11:333-338</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">D’Elia JA, Roshan B, Maski M, Larry A. Manifestation of Renal disease in obesity: pathophysiology of obesity-related dysfunction. Int J Nephrology and Renovascular Disease Dovepress 2009; 2:39-49</mixed-citation><mixed-citation xml:lang="en">D’Elia JA, Roshan B, Maski M, Larry A. Manifestation of Renal disease in obesity: pathophysiology of obesity-related dysfunction. Int J Nephrology and Renovascular Disease Dovepress 2009; 2:39-49</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Weinberg JM. Lipotoxicity. Kidney Int 2006; 70: 1560-1566</mixed-citation><mixed-citation xml:lang="en">Weinberg JM. Lipotoxicity. Kidney Int 2006; 70: 1560-1566</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Bagby SP. Obesity-initiated metabolic syndrome and the kidney: A recipe for Chronic kidney disease? J Am Soc Nephrol 2004; 15: 2775-2791</mixed-citation><mixed-citation xml:lang="en">Bagby SP. Obesity-initiated metabolic syndrome and the kidney: A recipe for Chronic kidney disease? J Am Soc Nephrol 2004; 15: 2775-2791</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Weinberg JM «Lipotoxicity.» Kidney Int 2006; 70: 1560- 1566</mixed-citation><mixed-citation xml:lang="en">Weinberg JM «Lipotoxicity.» Kidney Int 2006; 70: 1560- 1566</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Avramoglu RK, Qiu W, Adeli K. «Mechanisms of metabolic dyslipidemia in insulin resistant states: Deregulation of hepatic and intestinal lipoprotein secretion. Front Biosci 2003; 8: d464-d476</mixed-citation><mixed-citation xml:lang="en">Avramoglu RK, Qiu W, Adeli K. «Mechanisms of metabolic dyslipidemia in insulin resistant states: Deregulation of hepatic and intestinal lipoprotein secretion. Front Biosci 2003; 8: d464-d476</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Wahba IM, Mak RH. Obesity and Obesity-Initiated Metabolic Syndrome: Mechanistic Links to Chronic Kidney Disease. Clin J Am Soc Nephrol 2007; 2:550-562</mixed-citation><mixed-citation xml:lang="en">Wahba IM, Mak RH. Obesity and Obesity-Initiated Metabolic Syndrome: Mechanistic Links to Chronic Kidney Disease. Clin J Am Soc Nephrol 2007; 2:550-562</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Ruan XZ, Moorhead JF, Fernando R. Regulation of inflammatory mediators and transcription factors. Biochem Soc Trans 2004; 32: 88-91</mixed-citation><mixed-citation xml:lang="en">Ruan XZ, Moorhead JF, Fernando R. Regulation of inflammatory mediators and transcription factors. Biochem Soc Trans 2004; 32: 88-91</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Proctor G, Jiang T, Iwahashi M, Wang Z, Li J, Levi M. Regulation of renal fatty acid and cholesterol metabolism, inflammation, and fibrosis in Akita and OVE26 mice with type 1 diabetes. Diabetes 2006; 55: 2502-2509</mixed-citation><mixed-citation xml:lang="en">Proctor G, Jiang T, Iwahashi M, Wang Z, Li J, Levi M. Regulation of renal fatty acid and cholesterol metabolism, inflammation, and fibrosis in Akita and OVE26 mice with type 1 diabetes. Diabetes 2006; 55: 2502-2509</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Shankar SS, Steinberg HO. FFAs: Do they play a role in vascular disease in the insulin resistance syndrome? Curr Diab Rep 2005; 5: 30-35</mixed-citation><mixed-citation xml:lang="en">Shankar SS, Steinberg HO. FFAs: Do they play a role in vascular disease in the insulin resistance syndrome? Curr Diab Rep 2005; 5: 30-35</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Montani JP, Antic V, Yang Z, Dulloo A. Pathways from obesity to hypertension: From the perspective of a vicious triangle. Int J Obes relat metab Disord 2002; 26 (Suppl 20: S28-S38)</mixed-citation><mixed-citation xml:lang="en">Montani JP, Antic V, Yang Z, Dulloo A. Pathways from obesity to hypertension: From the perspective of a vicious triangle. Int J Obes relat metab Disord 2002; 26 (Suppl 20: S28-S38)</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Thomas ME, Morrison AR, Schreiner GF Metabolic effects of fatty acids exacerbate tubulointerstitial injury in proteinoverloaded proteinuria. Am J Physiol Renal Physiol 2002; 283: F640-F647</mixed-citation><mixed-citation xml:lang="en">Thomas ME, Morrison AR, Schreiner GF Metabolic effects of fatty acids exacerbate tubulointerstitial injury in proteinoverloaded proteinuria. Am J Physiol Renal Physiol 2002; 283: F640-F647</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Arici M, Chana R, Lewington A, Brown J, Brunskill NJ Stimulation of proximal tubular cell apoptosis by albumin-bound fatty acids mediated by peroxisome proliferator activated receptorgamma. J Am Soc Nephrol 2003; 14: 17-27</mixed-citation><mixed-citation xml:lang="en">Arici M, Chana R, Lewington A, Brown J, Brunskill NJ Stimulation of proximal tubular cell apoptosis by albumin-bound fatty acids mediated by peroxisome proliferator activated receptorgamma. J Am Soc Nephrol 2003; 14: 17-27</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Hajiwara S, Makita Y, Gu l et al. Eicosopentanoic acid ameliorates diabetic nephropathy of type 2 diabetic KKay/TA mice: involvement of MCP1 suppression and decreased ERK1/2 and p 38 phosphorylation. Nephrol Dial transplant 2006; 21: 605-615</mixed-citation><mixed-citation xml:lang="en">Hajiwara S, Makita Y, Gu l et al. Eicosopentanoic acid ameliorates diabetic nephropathy of type 2 diabetic KKay/TA mice: involvement of MCP1 suppression and decreased ERK1/2 and p 38 phosphorylation. Nephrol Dial transplant 2006; 21: 605-615</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Hirosumi J et al. A central role for JNK in obesity and insuline resistance. Nature 2002; 420: 333-336</mixed-citation><mixed-citation xml:lang="en">Hirosumi J et al. A central role for JNK in obesity and insuline resistance. Nature 2002; 420: 333-336</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112: 1796-1808</mixed-citation><mixed-citation xml:lang="en">Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112: 1796-1808</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Wisse BE. The inflammatory syndrome: The role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol 2004; 15: 2792-2800</mixed-citation><mixed-citation xml:lang="en">Wisse BE. The inflammatory syndrome: The role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol 2004; 15: 2792-2800</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R. Metabolic syndrome: A comprehensive perspective based on interactions between obesity, diabetes and inflammation. Circulation 2005; 111: 1448-1454</mixed-citation><mixed-citation xml:lang="en">Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R. Metabolic syndrome: A comprehensive perspective based on interactions between obesity, diabetes and inflammation. Circulation 2005; 111: 1448-1454</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Wu Y, Liu Z, Xiang Z, Zeng C, Chen Z, Ma X, Li L. Obesityrelated glomerulopathy: Insights from gene expression profiles of the glomeruli derived from renal biopsy samples. Endocrinology 2006; 147: 44-50</mixed-citation><mixed-citation xml:lang="en">Wu Y, Liu Z, Xiang Z, Zeng C, Chen Z, Ma X, Li L. Obesityrelated glomerulopathy: Insights from gene expression profiles of the glomeruli derived from renal biopsy samples. Endocrinology 2006; 147: 44-50</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Way JM et al. Comprehensive messenger ribonucleic acid profiling reveals that peroxisome proliferator-activated receptor gamma activation has coordinate effects on gene expression in multiple insuline-sensitive tissues. Endocrinology 2001; 142: 1269-1277</mixed-citation><mixed-citation xml:lang="en">Way JM et al. Comprehensive messenger ribonucleic acid profiling reveals that peroxisome proliferator-activated receptor gamma activation has coordinate effects on gene expression in multiple insuline-sensitive tissues. Endocrinology 2001; 142: 1269-1277</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Малявская CB, Лебедев АВ, Терновская ВА. Значение хронической бессимптомной гиперурикемии как маркера атерогенного риска у детей. Кардиология 2007; 3: 62-67</mixed-citation><mixed-citation xml:lang="en">Малявская CB, Лебедев АВ, Терновская ВА. Значение хронической бессимптомной гиперурикемии как маркера атерогенного риска у детей. Кардиология 2007; 3: 62-67</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">Lauren F L, Navas-Acien A, Tammy M, Brady et al. Uric Acid Level and Elevated Blood pressure in US Adolescents. prehyper. ahajournals.org/content/early/2012/02/21/HYPERTENSIONAHA.111.183244.abstract</mixed-citation><mixed-citation xml:lang="en">Lauren F L, Navas-Acien A, Tammy M, Brady et al. Uric Acid Level and Elevated Blood pressure in US Adolescents. prehyper. ahajournals.org/content/early/2012/02/21/HYPERTENSIONAHA.111.183244.abstract</mixed-citation></citation-alternatives></ref><ref id="cit63"><label>63</label><citation-alternatives><mixed-citation xml:lang="ru">Veeraish Chauhan et al. The Obesity Epidemic and Kidney disease: a Literature Review. In:Manisha S,ed. Diseases of Renal parenchyma. Published on line 16 March, 2012; 5-17</mixed-citation><mixed-citation xml:lang="en">Veeraish Chauhan et al. The Obesity Epidemic and Kidney disease: a Literature Review. In:Manisha S,ed. Diseases of Renal parenchyma. Published on line 16 March, 2012; 5-17</mixed-citation></citation-alternatives></ref><ref id="cit64"><label>64</label><citation-alternatives><mixed-citation xml:lang="ru">Chikako Oyama, Nsutomu Takahashi, Mika Oyamada et al. «Serum Uric Acid as an Obesity-Related Indicator in Early Adolescence. Tohoku J Exp Med 2006; 209: 257-262</mixed-citation><mixed-citation xml:lang="en">Chikako Oyama, Nsutomu Takahashi, Mika Oyamada et al. «Serum Uric Acid as an Obesity-Related Indicator in Early Adolescence. Tohoku J Exp Med 2006; 209: 257-262</mixed-citation></citation-alternatives></ref><ref id="cit65"><label>65</label><citation-alternatives><mixed-citation xml:lang="ru">Wright AF, I. Rudan ND, Hastie H, Campbell A. ‘Complexity’ of Urate transporters. Kidney Int 2010; 78:446-452</mixed-citation><mixed-citation xml:lang="en">Wright AF, I. Rudan ND, Hastie H, Campbell A. ‘Complexity’ of Urate transporters. Kidney Int 2010; 78:446-452</mixed-citation></citation-alternatives></ref><ref id="cit66"><label>66</label><citation-alternatives><mixed-citation xml:lang="ru">Миняйлова НН, Казакова ЛМ. Диагностические аспекты гипоталамического и метаболического синдромов у детей. Педиатрия 2002; 4: 98-101</mixed-citation><mixed-citation xml:lang="en">Миняйлова НН, Казакова ЛМ. Диагностические аспекты гипоталамического и метаболического синдромов у детей. Педиатрия 2002; 4: 98-101</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
